Stockreport

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma [Yahoo! Finance]

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF OS benefit observed across key subgroups, including patients with high tumor burden, elevated LDH, and extrahepatic disease as well as those with best response of progr [Read more]